On July 30, 2026, Catheter Precision, Inc. closed the sale of 2,821 shares of Series C-4 Convertible Preferred Stock for aggregate gross proceeds of $2,821,000. The issuance was executed under an Additional Investment Right within a Securities Purchase Agreement dated March 9, 2026, with Dawson James Securities acting as placement agent. Proceeds are designated for working capital, general corporate purposes, and the redemption of outstanding Series B Convertible Preferred Stock. This transaction involves unregistered equity securities exempt from registration under Regulation D and results in dilution to existing common shareholders. Catheter Precision, Inc. operates in the medical device industry, specializing in catheter technologies.

Catheter Precision, Inc. filed an amendment to its March 9, 2026 Form 8-K/A to include audited financial statements and pro forma information for its acquisition of Fly Flyte, Inc. and Ponderosa Air, LLC. The transaction was completed on March 9, 2026, with Catheter Precision acquiring 100% ownership through a combination of cash, promissory notes, and Series D Preferred Stock issuance. The aggregate purchase price was $11,554,827, comprising approximately $5.8 million in cash (including a $5 million note) and $5.8 million in equity. Pro forma results for the year ended December 31, 2025, show combined revenues of $1.8 million and a net loss of $23.3 million, reflecting transaction costs and purchase accounting adjustments including $10.1 million in goodwill. Catheter Precision operates in the medical device industry.

Catheter Precision, Inc. closed the sale and issuance of 3,470 shares of Series C-3 Convertible Preferred Stock for aggregate gross proceeds of $3,470,000. The preferred stock is convertible into common stock at an initial conversion price of $0.632 per share, subject to a floor price of $0.35 per share. The company intends to use the net proceeds for working capital, loan repayment, and general corporate purposes. Catheter Precision, Inc. operates in the medical device industry and develops precision catheter technology.

Catheter Precision, Inc. entered into a Securities Purchase Agreement with Volato Group, Inc. to purchase 2,941,176 shares of Volato common stock at $0.34 per share for a total of $1,000,000. In exchange, Volato will deliver certain freely tradeable equity securities of a third-party entity valued at approximately $1,100,000.